Articles

Despite being on first-line oral anti-diabetic drug therapy, the risk of developing CVD/CKD in patients with type 2 diabetes remains high.

The Look AHEAD trial had dramatic results for patients with T2D and their risk for cardiovascular disease (CVD). 

How does intensive medical therapy (IMT) compare with surgical treatment in improving patients' quality of life? 

Black patients may have lower odds of achieving target HbA1C levels on metformin and SGLT2 alone. 

A 16-week low-fat plant-based diet significantly improves diabetes parameters in adult patients with type 2 diabetes mellitus (T2DM). 

Is the current guidelines’ recommendation of moderate exercise for 150 minutes per week during pregnancy enough to reduce the risk of gestational diabetes? 

Examining how curcumin and other bioactive compounds in turmeric lower blood glucose.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors were created to treat diabetes, but noted to ameliorate cardiovascular events. 

Health plans with high deductibles require thousands of dollars out-of-pocket and have a known association with delays in treatment; a repeated cross-sectional study found they are also associated with medication non-adherence.

The case for why an SGLT2 inhibitor or GLP-1 receptor agonist should be initiated early in diabetes treatment, regardless of whether the patient is on insulin therapy.